Table 3 |
|||
|
Clinical results at 12 weeks follow-up (mean ± SD) |
|||
|
Parameter/Group |
(1) NexGen Control (n = 28) |
(2) NexGen navigated (n = 29) |
(3) Scorpio navigated (n = 30) |
|
|
|||
|
Knee society score (Knee) |
69.5 ± 16.9 |
74.1 ± 20.4 |
58.5 ± 19.5* |
|
|
|||
|
Knee society score (Function) |
68.2 ± 16.3 |
69.3 ± 15.8 |
59.5 ± 20.2* |
|
|
|||
|
Pain [Visual analogue scale 0-10] |
2.0 ± 1.5 |
2.2 ± 1.7 |
3.3 ± 2.3* |
|
|
|||
|
Schmitt et al. BMC Musculoskeletal Disorders 2011 12:16 doi:10.1186/1471-2474-12-16 |
|||